Susquehanna International Group’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Buy |
152,338
+41,362
| +37% | +$48K | ﹤0.01% | 5629 |
|
|
2025
Q1 | $122K | Buy |
110,976
+35,088
| +46% | +$38.6K | ﹤0.01% | 5782 |
|
|
2024
Q4 | $131K | Buy |
75,888
+21,869
| +40% | +$37.6K | ﹤0.01% | 5555 |
|
|
2024
Q3 | $134K | Sell |
54,019
-61
| -0.1% | -$151 | ﹤0.01% | 5007 |
|
|
2024
Q2 | $131K | Sell |
54,080
-211,763
| -80% | -$512K | ﹤0.01% | 4993 |
|
|
2024
Q1 | $1.08M | Sell |
265,843
-233,951
| -47% | -$948K | ﹤0.01% | 2540 |
|
|
2023
Q4 | $1.92M | Buy |
499,794
+322,015
| +181% | +$1.24M | ﹤0.01% | 1995 |
|
|
2023
Q3 | $738K | Buy |
+177,779
| New | +$738K | ﹤0.01% | 2925 |
|
|
2023
Q2 | – | Sell |
-129,794
| Closed | -$527K | – | 5593 |
|
|
2023
Q1 | $527K | Buy |
129,794
+40,233
| +45% | +$163K | ﹤0.01% | 3742 |
|
|
2022
Q4 | $484K | Buy |
89,561
+62,561
| +232% | +$338K | ﹤0.01% | 3266 |
|
|
2022
Q3 | $271K | Buy |
27,000
+826
| +3% | +$8.29K | ﹤0.01% | 4358 |
|
|
2022
Q2 | $123K | Buy |
+26,174
| New | +$123K | ﹤0.01% | 4890 |
|